The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

ZÁZNAM | Proběhlo Pá, 22.1.2021
Tento webinář představí výzvy, kterým analytické laboratoře čelí při analýze bioterapeutik a jak lze překonat problémy s narušením integrity vzorku a povrchové interakce.
Agilent Technologies: The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules
Agilent Technologies: The benefits of dedicated Biocompatible UHPLC and chromatography column for analysis of Biomolecules

High performance liquid chromatography with optical detection or coupled to mass spectrometry are fundamental methods characterization and quality control of biopharmaceutical products. Biotherapeutic molecules represent a versatile class of compounds that need special attention for sample preparation, LC instrumentation, and type of chromatography columns used.

Presenter: Manu Grover (Business Manager, Agilent Technologies, India)

Presenter: Vinayak AK (Product Specialist, Agilent Technologies, India)

Presenter: Cornelia Vad (Senior Product Manager Analytical HPLC, Agilent Technologies)

Presenter: Dr. Andrew Coffey (Senior Applications Chemist, Agilent Technologies)

Agilent Technologies
LinkedIn Logo